Patents by Inventor Anamaria Crisan

Anamaria Crisan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220349011
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Application
    Filed: June 11, 2021
    Publication date: November 3, 2022
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
  • Patent number: 11035005
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: June 15, 2021
    Assignees: Decipher Biosciences, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
  • Publication number: 20140066323
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Application
    Filed: August 16, 2013
    Publication date: March 6, 2014
    Applicants: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, GENOMEDX BIOSCIENCES INC.
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa